Anakinra for rheumatoid arthritis
Author:
Affiliation:
1. University of Minnesota; 596 Grand Ave., Apt 1 Saint Paul 55102 USA Minnesota
2. Minneapolis VA Medical Center; Medicine; 1 Veterans Drive Rheumatology (111R) Minneapolis MN USA 55417
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005121.pub3/fullpdf
Reference73 articles.
1. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist;Bresnihan;Arthritis & Rheumatism,1998
2. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial;Cohen;Arthritis & Rheumatism,2002
3. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate;Cohen;Annals of the Rheumatic Diseases,2004
4. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial;Fleischmann;Arthritis & Rheumatism,2003
5. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate;Genovese;Arthritis & Rheumatism,2004
Cited by 161 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22
2. Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches;Frontiers in Immunology;2024-03-11
3. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17
4. The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review;International Journal of Molecular Sciences;2024-01-03
5. Modeling and Simulation of anakinra effects on severe COVID19 Patients;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3